secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2024-09-19T23:59:59+00:00
Accession:  0001193125-24-222116
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience approves retention bonuses for CEO ($390K) and CFO ($220K) through Mar 2025 or change of control
--------------------------------------------------------------------------------

- CEO David J. Lennon eligible for $390,000 retention bonus if employed through Mar 31, 2025 or Change of Control.
- CFO Scott Giacobello eligible for $220,000 retention bonus under same conditions.
- If terminated without cause or resign for good reason before retention date, severance payment equal to bonus (subject to release).
- Retention bonus program approved by Compensation Committee on Sept 15, 2024; letters executed Sept 18, 2024.
- No change in at-will employment status; bonus is not part of base compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524222116/0001193125-24-222116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524222116/d880684d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-222116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer